FDA grants fast track designation to azer-cel, an allogeneic CAR T-cell therapy, for relapsed or refractory diffuse large ...

CTEs contain multiple domains, with the simplest form comprising a protein target for a CAR T cell, for example the CD19 extracellular domain, linked to an antibody fragment that binds to a second ...

Sana revolutionizes treatments for diabetes, cancer, and autoimmune diseases. SANA has high cash burn and dilution risks. See ...

Why Trust Us? Unfortunately, the market is flooded with options, making it hard to know which are the best protein bars out there. “Not all protein bars are created equal, and many on the market ...

High-protein snacks can satisfy hunger between meals and provide nutrients as part of an overall healthy diet. High-protein snacks have been shown to have positive effects on blood sugar while also ...

CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

In March 2025, Celgene announced a study is to compare the effectiveness and safety of golcadomide in combination with ...

B-cell acute lymphoblastic leukemia (B-ALL) is a life-threatening and highly aggressive form of blood cancer. It is the most common childhood cancer, making up 35% of pediatric cancer cases, but it ...

Protein folding is the process by which proteins achieve their mature functional (native) tertiary structure, and often begins co-translationally. Protein folding requires chaperones and often ...

Treatment of B-cell acute lymphoblastic leukemia has improved thanks to CAR T therapies, but relapse is still very common. An ...

At close: March 21 at 4:00:00 PM EDT Loading Chart for CASI ...

Q4 2024 Earnings Call Transcript March 20, 2025 Monte Rosa Therapeutics, Inc. beats earnings expectations. Reported EPS is $0 ...